Dr. Tarapore’s research interest focuses on finding effective RNA therapies to target advanced cancers, and to develop more sensitive and specific bio-imaging agents. Our studies are aimed at developing a RNA aptamer based approach for treating prostate and ovarian cancers. This involves development of RNA vehicles to deliver pro-apoptotic microRNA and siRNA targeting pro-survival genes, to specific tissues. The RNA vehicles consist of the relatively non-immunogenic and stable RNA aptamers specific for prostate or ovarian cancer cells. Dr. Tarapore is also developing various strategies to engineer the delivery vehicle and couple it with the therapeutic components to increase efficiency of delivery.